全文获取类型
收费全文 | 6165篇 |
免费 | 286篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 202篇 |
儿科学 | 64篇 |
妇产科学 | 107篇 |
基础医学 | 673篇 |
口腔科学 | 112篇 |
临床医学 | 375篇 |
内科学 | 1498篇 |
皮肤病学 | 81篇 |
神经病学 | 810篇 |
特种医学 | 197篇 |
外科学 | 1044篇 |
综合类 | 15篇 |
预防医学 | 151篇 |
眼科学 | 120篇 |
药学 | 477篇 |
中国医学 | 11篇 |
肿瘤学 | 535篇 |
出版年
2023年 | 29篇 |
2022年 | 65篇 |
2021年 | 99篇 |
2020年 | 74篇 |
2019年 | 75篇 |
2018年 | 122篇 |
2017年 | 99篇 |
2016年 | 83篇 |
2015年 | 101篇 |
2014年 | 132篇 |
2013年 | 181篇 |
2012年 | 280篇 |
2011年 | 267篇 |
2010年 | 135篇 |
2009年 | 133篇 |
2008年 | 231篇 |
2007年 | 282篇 |
2006年 | 247篇 |
2005年 | 277篇 |
2004年 | 260篇 |
2003年 | 277篇 |
2002年 | 259篇 |
2001年 | 262篇 |
2000年 | 251篇 |
1999年 | 207篇 |
1998年 | 61篇 |
1997年 | 49篇 |
1996年 | 50篇 |
1995年 | 40篇 |
1994年 | 55篇 |
1993年 | 43篇 |
1992年 | 194篇 |
1991年 | 171篇 |
1990年 | 140篇 |
1989年 | 178篇 |
1988年 | 121篇 |
1987年 | 130篇 |
1986年 | 97篇 |
1985年 | 95篇 |
1984年 | 62篇 |
1983年 | 58篇 |
1982年 | 27篇 |
1979年 | 51篇 |
1978年 | 29篇 |
1977年 | 30篇 |
1976年 | 29篇 |
1975年 | 32篇 |
1974年 | 37篇 |
1973年 | 33篇 |
1972年 | 32篇 |
排序方式: 共有6472条查询结果,搜索用时 15 毫秒
101.
The matrix proteins of neurovirulent subacute sclerosing panencephalitis virus and its acute measles virus progenitor are functionally different. 下载免费PDF全文
A Hirano A H Wang A F Gombart T C Wong 《Proceedings of the National Academy of Sciences of the United States of America》1992,89(18):8745-8749
Persistence of measles virus in the brains of patients with subacute sclerosing panencephalitis (SSPE) is accompanied by changes in the viral matrix (M) protein. To understand the significance of these changes, cell culture and cell-free assays were developed to compare the functions of the M proteins of an SSPE virus Biken strain and its acute measles virus progenitor Nagahata strain. The Nagahata viral M protein is associated with the intracellular viral nucleocapsids and the plasma membrane, whereas the Biken viral M protein is localized mainly in the cytosol. The lack of M protein in the Biken viral nucleocapsids is due to a failure of the Biken M protein to bind to the viral nucleocapsids. The Biken M protein also fails to bind to the Nagahata viral nucleocapsids. Conversely, the Nagahata M protein can bind to the Biken viral nucleocapsids, although this association is not as stable at physiological salt concentration. These results offer concrete evidence that the M protein of an SSPE virus is functionally different from that of its progenitor acute measles virus. 相似文献
102.
Yuta Aizawa Kanako Watanabe Tomohiro Oishi Harunobu Hirano Isao Hasegawa Akihiko Saitoh 《Emerging infectious diseases》2015,21(11):1966-1972
Human parechovirus type 3 (HPeV3) is an emerging pathogen that causes sepsis and meningoencephalitis in young infants. To test the hypothesis that maternal antibodies can protect this population, we measured neutralizing antibody titers (NATs) to HPeV3 and other genotypes (HPeV1 and HPeV6) in 175 cord blood samples in Japan. The seropositivity rate (>1:32) for HPeV3 was 61%, similar to that for the other genotypes, but decreased significantly as maternal age increased (p<0.001). Furthermore, during the 2014 HPeV3 epidemic, prospective measurement of NATs to HPeV3 in 45 patients with severe diseases caused by HPeV3 infection showed low NATs (<1:16) at onset and persistently high NATs (>1:512) until age 6 months. All intravenous immunoglobulin samples tested elicited high NATs to HPeV3. Our findings indicate that maternal antibodies to HPeV3 may help protect young infants from severe diseases related to HPeV3 and that antibody supplementation may benefit these patients. 相似文献
103.
Padrão Eduardo Messias Hirano Bustos Brian Mahesh Ashwin Fonseca Guilherme Henrique Hencklain Taniguchi Leandro Utino 《Annals of hematology》2022,101(9):1951-1957
Annals of Hematology - Sickle cell disease (SCD) is associated with multiple known complications and increased mortality. This study aims to further understand the profile of intensive care unit... 相似文献
104.
105.
Koba S Hirano T Murayama S Kotani T Tsunoda F Iso Y Ban Y Kondo T Suzuki H Katagiri T 《Atherosclerosis》2003,170(1):131-140
BACKGROUND: The small dense low-density lipoprotein (LDL) phenotype (pattern B), high concentrations of remnant-like particles (RLPs), and postprandial lipemia are newly recognized risk factors for coronary heart disease (CHD). However, the associations of these lipoprotein abnormalities remain unclear. The aim of this study was to investigate the relationships among LDL phenotype, very-low-density lipoprotein (VLDL) subclasses, and postprandial lipoprotein metabolism in CHD patients. METHOD: We performed an oral fat tolerance test in 32 patients with acute myocardial infarction and compared the following parameters between patients characterized by either large buoyant LDL (pattern A) versus pattern B: lipids and apolipoproteins (apo) in the plasma and Svedberg flotation rates (Sf) >400 (chylomicron), Sf 60-400 (large VLDL), and Sf 20-60 (small VLDL) fractions. RESULT: Fasting levels of triglyceride, RLP-cholesterol and RLP-triglyceride were slightly higher in the pattern B patients. Postprandial increases of RLP-cholesterol and the cholesterol and triglyceride of large VLDL fractions were significantly greater in the pattern B patients. The areas under the curves of cholesterol, triglyceride, and apo-B in large VLDL fractions were significantly higher in pattern B, while those in small VLDL were not. RLP-cholesterol and RLP-triglyceride in fasting and fed states correlated very highly with the corresponding cholesterol and triglyceride concentrations in large VLDL fractions. CONCLUSION: These results suggest that postprandial increase of large VLDL fractions and RLPs contribute to the formation of small dense LDL in CHD patients. 相似文献
106.
Shigemoto Yoko Matsuda Hiroshi Kimura Yukio Chiba Emiko Ohnishi Masahiro Nakaya Moto Maikusa Norihide Ogawa Masayo Mukai Yohei Takahashi Yuji Sako Kazuya Toyama Hiroshi Inui Yoshitaka Taki Yasuyuki Nagayama Hiroshi Ono Kenjiro Kono Atsushi Sekiguchi Kenji Hirano Shigeki Sato Noriko 《Annals of nuclear medicine》2022,36(5):460-467
Annals of Nuclear Medicine - Although previous studies have investigated age and gender effects on striatal subregional dopamine transporter (DaT) binding, these studies were mostly based on a... 相似文献
107.
108.
Takayama Y Moriura S Nagata J Akutagawa A Hirano A Ishiguro S Matsumoto T Sato T 《Journal of gastroenterology and hepatology》2001,16(12):1425-1428
Diagnostic imaging and embolization therapy for very rare intrahepatic portal-systemic shunts with liver cirrhosis are reported. An 82-year-old woman was admitted to the hospital (Yachiyo Hospital) because of hepatic encephalopathy. Computed tomography with contrast enhancement demonstrated anomalous vessels between the portal vein and the inferior vena cava. Those shunts were suspected as the cause of her encephalopathy with hyperammonemia. Portography through McBurney's laparotomy demonstrated two portal-caval shunts; one was from the bifurcation of the portal vein and the other was from the left portal vein. They seemed to originate from the vascular system of the caudate lobe, and were obstructed with stainless coils. The patient is well with a normal serum ammonia level 40 months following the intervention. 相似文献
109.
Fukuhara T Miyake T Maekawa I Kurosawa M Suzuki S Noto S Mori A Chiba K Toyoshima T Hirano T Morioka M Tsutsumi Y Okabe M Kakinoki Y 《International journal of hematology》2000,71(4):366-371
The treatment of patients with aggressive subclasses of myelodysplastic syndrome (MDS) remains a challenge. In an effort to improve the survival of patients with refractory anemia with excess blasts (RAEB), RAEB in transformation (RAEB-t), or acute myelogenous leukemia transformed from MDS (MDS-AML), we conducted a small trial in which 28 such patients were treated with low-dose cytosine arabinoside (LDAraC) followed by administration of macrophage colony-stimulating factor (M-CSF). The overall rate of response to the treatment was 61%, including 39% with a complete response, which is higher than rates obtained in previous studies in which LDAraC alone was administered to patients with MDS. Median survival was 23.5 months in cases of RAEB, 16.7 months in cases of RAEB-t, and 19.7 months in cases of MDS-AML. The overall survival of the study group appeared to be prolonged in comparison with a historical control group of patients treated with LDAraC alone. It is suggested that M-CSF added to the administration of LDAraC plays an active role in the therapy. No therapy-related death occurred. Some unique actions of M-CSF were suggested in this trial. It is concluded that therapy with LDAraC + M-CSF is a useful treatment option for patients with aggressive subclasses of MDS and MDS-AML to provide better response and survival. 相似文献
110.